These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3318087)

  • 1. [Current status of vaccine development in sexually transmissible diseases].
    Kohl PK; Hennes B; Näher H; Schröter R; Petzoldt D
    Urologe A; 1987 Sep; 26(5):277-82. PubMed ID: 3318087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine candidates in STD.
    Fletcher MA
    Int J STD AIDS; 2002 Dec; 13 Suppl 2():38-41. PubMed ID: 12537725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine candidates in STD.
    Fletcher MA
    Int J STD AIDS; 2001 Jul; 12(7):419-22. PubMed ID: 11394975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital ulcers and concomitant complaints in men attending a sexually transmitted infections clinic: implications for sexually transmitted infections management.
    O'Farrell N; Morison L; Moodley P; Pillay K; Vanmali T; Quigley M; Sturm AW
    Sex Transm Dis; 2008 Jun; 35(6):545-9. PubMed ID: 18356769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pre- and perinatal infections with sexually transmissible microorganisms].
    Schiefer HG; Willems WR
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):376-87. PubMed ID: 1922115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future prospects for new vaccines against sexually transmitted infections.
    Gottlieb SL; Johnston C
    Curr Opin Infect Dis; 2017 Feb; 30(1):77-86. PubMed ID: 27922851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps.
    Gottlieb SL; Deal CD; Giersing B; Rees H; Bolan G; Johnston C; Timms P; Gray-Owen SD; Jerse AE; Cameron CE; Moorthy VS; Kiarie J; Broutet N
    Vaccine; 2016 Jun; 34(26):2939-2947. PubMed ID: 27105564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental perspectives on vaccinating children against sexually transmitted infections.
    Mays RM; Sturm LA; Zimet GD
    Soc Sci Med; 2004 Apr; 58(7):1405-13. PubMed ID: 14759685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
    Garnett GP
    J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexually transmitted diseases: risks, transmission, and laboratory diagnostic update.
    Kwa B; Pentella M
    Clin Lab Sci; 1993; 6(2):85-9. PubMed ID: 10148587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in vaccines for sexually transmitted diseases.
    Stanberry LR; Rosenthal SL
    Infect Dis Clin North Am; 2005 Jun; 19(2):477-90, xi. PubMed ID: 15963884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.
    Wu JJ; Huang DB; Pang KR; Tyring SK
    J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological views into possible components of paediatric combined vaccines in 2015.
    Eskola J
    Biologicals; 1994 Dec; 22(4):323-7. PubMed ID: 7779356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatrics and herpes simplex virus vaccines.
    Rupp R; Rosenthal SL; Stanberry LR
    Semin Pediatr Infect Dis; 2005 Jan; 16(1):31-7. PubMed ID: 15685147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for classic sexually transmitted diseases.
    Adimora AA; Sparling PF; Cohen MS
    Infect Dis Clin North Am; 1994 Dec; 8(4):859-76. PubMed ID: 7890936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia.
    Garland SM; Tabrizi SN; Chen S; Byambaa C; Davaajav K
    Infect Dis Obstet Gynecol; 2001; 9(3):143-6. PubMed ID: 11516062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.